CRISPR Therapeutics
CRSP
#2966
Rank
C$6.12 B
Marketcap
$71.79
Share price
-0.50%
Change (1 day)
1.44%
Change (1 year)

CRISPR Therapeutics (CRSP) - Total debt

Total debt on the balance sheet as of June 2024 : C$0.32 Billion

According to CRISPR Therapeutics's latest financial reports the company's total debt is C$0.32 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

CRISPR Therapeutics - Total debt on balance sheet (from 2015 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.31 B-4.41%
2022-12-31C$0.33 B15.46%
2021-12-31C$0.28 B266.14%
2020-12-31C$78.32 M14.15%
2019-12-31C$68.61 M
2018-12-31N/A
2015-12-31C$53.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$3.85 M-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA